Navigation Links
MEDEX / Harvard Partnership Now Offers Affordable, New Intelligence to Individual Business & Leisure Travelers
Date:1/29/2008

MEDEX 360m Collaboration with Harvard Medical International Provides

Comprehensive and Vital Global Health Information

BALTIMORE, Jan. 29 /PRNewswire/ -- MEDEX Global Group and Harvard Medical International have extended the reach of their groundbreaking MEDEX 360m partnership with the launch today of a new version created specifically for individual business and leisure travelers.

Like the original MEDEX 360m website recently introduced for corporate, scholastic and government clients, this individual-traveler edition of the MEDEX 360m Global Medical Monitor provides vital and timely health risk and medical care information in an easy-to-read report format.

MEDEX 360m Monitors cover 236 countries and territories with destination- specific information on diseases / health risks; immunization requirements / recommendations; the quality / availability of local care; health alerts / updates; travel health prevention / advice; and health risk ratings. The unique one-to-five rating system allows travelers to quickly see what the primary concerns are for each country -- whether medical infrastructure, remoteness to quality care, or cultural barriers, such as language or local medical practices.

Priced at only $8.95 each, MEDEX 360m Monitors are an easy add-on during the purchase of any individual emergency evacuation or international medical insurance plan; which are priced as low as $2.00 per day or less. The coverage and destination report combination are only available through the MEDEX website: http://www.medex360m.com.

MEDEX 360m Monitors are delivered via a live web link that is active through the last day of their coverage period, so travelers can view their report upon purchase, before and during their trip. Travelers are encouraged revisit their reports to benefit from the up-to-date alerts maintained by MEDEX and Harvard Medical International.

Abo
'/>"/>

SOURCE MEDEX Global Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
2. MEDEX 360m Rates the State of Global Medical Care for Travelers
3. How Best to Treat Preschoolers With ADHD? The Harvard Mental Health Letter Discusses the Options
4. Link Uncovered Between Benign Prostatic Hyperplasia and NSAIDs, Says Harvard Mens Health Watch
5. Harvard Researchers Select S.C. BlueCross for National Honor
6. Excessive Multivitamin Use May Raise Risk for Prostate Cancer, from Harvard Mens Health Watch
7. Strawberry Consumption Associated with C-Reactive Protein Among Women: New Harvard Study
8. Fighting the Gassy Effects of Good Eating, From the Harvard Health Letter
9. Cautious Optimism for New Alzheimers Medications, Reports the Harvard Mental Health Letter
10. National healthcare advocate from Harvard Med School to speak at NJIT
11. Antibiotics May Not Help Mens Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8FDA Acknowledges Mistakes in Knee Device Approval 58323 1FDA Acknowledges Mistakes in Knee Device Approval 58323 2Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 1Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2